(1 - 15 from 17
)
ALS drug approved by Health Canada could slow down ...
globalnews.ca
· “ALS is one of the most serious neurodegenerative diseases due to the crippling loss of function,” Dr. Angela Genge, director of the clinical research unit and ALS clinic, Montreal ...
Busy week for ALS research and awareness - webadmin.mcgill.ca
www.mcgill.ca
On Sept. 14 The Neuro will host ALS Education Day in collaboration with ALS Quebec, beginning at 9 a.m. with opening remarks in the Jeanne Timmins Amphitheatre by Dr. Angela Genge, Director of The Neuro’s ALS Clinic and the Clinical Research Unit. This will be followed by a full day of presentations on ALS diagnosis, treatment, and care for ...
National Clinical Trial Training Program | Le Neuro ...
www.mcgill.ca
Third Annual National Clinical Trial Training Program June , De Grandpré Communications Centre Chair: Dr. Angela Genge, Director, Clinical Research Unit Montreal Neurological Institute and Hospital The Neuro’s Clinical Research Unit (CRU) will host its Third Annual National Clinical Trial Training Program on June 14 & 15, Principal investigators, researchers, clinical ...
June is ALS Awareness Month | McGill University Health Centre
muhc.ca
Dr. Angela Genge is a neurologist, Director of the Clinical Research Unit and the ALS Clinic. She is a very active clinical investigator and is ...
sorted by relevance / date